304 related articles for article (PubMed ID: 37822923)
21. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis.
Mo S; Wang Y; Yuan X; Wu W; Zhao H; Wei H; Qin H; Jiang H; Qin S
Front Cardiovasc Med; 2023; 10():1142296. PubMed ID: 37063958
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics reveals diagnostic potential of cuproptosis-related genes in the pathogenesis of sepsis.
Sun Z; Zhao Q; Zhang J; Hu Y; Qu J; Gao H; Peng Z
Heliyon; 2024 Jan; 10(1):e22664. PubMed ID: 38163157
[TBL] [Abstract][Full Text] [Related]
23. Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis.
Jia F; Zhang B; Yu W; Chen Z; Xu W; Zhao W; Wang Z
Comput Biol Med; 2024 Jan; 168():107776. PubMed ID: 38056214
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics Prediction and Experimental Validation Identify a Novel Cuproptosis-Related Gene Signature in Human Synovial Inflammation during Osteoarthritis Progression.
Wang W; Chen Z; Hua Y
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671512
[TBL] [Abstract][Full Text] [Related]
25. Identification of immunological characteristics and cuproptosis-related molecular clusters in primary Sjögren's syndrome.
Wei B; Wang A; Liu W; Yue Q; Fan Y; Xue B; Wang S
Int Immunopharmacol; 2024 Jan; 126():111251. PubMed ID: 37984252
[TBL] [Abstract][Full Text] [Related]
26. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
27. Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
Tian X; Zhu S; Liu W; Wu X; Wei G; Zhang J; Anwaier A; Chen C; Ye S; Che X; Xu W; Qu Y; Zhang H; Ye D
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17451-17466. PubMed ID: 37889309
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
[TBL] [Abstract][Full Text] [Related]
29. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
30. Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis.
Chen YT; Xu XH; Lin L; Tian S; Wu GF
Int J Med Sci; 2023; 20(7):836-848. PubMed ID: 37324184
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
Xin G; Niu J; Tian Q; Fu Y; Chen L; Yi T; Tian K; Sun X; Wang N; Wang J; Zhang H; Wang L
PLoS One; 2023; 18(12):e0294984. PubMed ID: 38051734
[TBL] [Abstract][Full Text] [Related]
32. Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values.
Zou M; Zhang W; Zhu Y; Xu Y
Medicine (Baltimore); 2023 Oct; 102(43):e35503. PubMed ID: 37904461
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
34. Identification and immuno-infiltration analysis of cuproptosis regulators in human spermatogenic dysfunction.
Zhao M; Yu WX; Liu SJ; Deng YJ; Zhao ZW; Guo J; Gao QH
Front Genet; 2023; 14():1115669. PubMed ID: 37065492
[No Abstract] [Full Text] [Related]
35. Integrated bioinformatics and experiment revealed that cuproptosis is the potential common pathogenesis of three kinds of primary cardiomyopathy.
Wang M; Xu X; Li J; Gao Z; Ding Y; Chen X; Xiang Q; Shen L
Aging (Albany NY); 2023 Dec; 15(23):14210-14241. PubMed ID: 38085668
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
[TBL] [Abstract][Full Text] [Related]
37. A broad cuproptosis landscape in inflammatory bowel disease.
Chen Y; Li X; Sun R; Ji J; Yang F; Tian W; Ji W; Huang Q
Front Immunol; 2022; 13():1031539. PubMed ID: 36405733
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a cuproptosis-related diagnostic gene signature for atrial fibrillation based on ensemble learning.
Wang Y; Wang Q; Liu P; Jin L; Qin X; Zheng Q
Hereditas; 2023 Aug; 160(1):34. PubMed ID: 37620966
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease.
Li J; Kou C; Sun T; Liu J; Zhang H
Int J Gen Med; 2023; 16():2609-2621. PubMed ID: 37362825
[TBL] [Abstract][Full Text] [Related]
40. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
